TransCelerate eyes GCP standard; Accelovance doubles down on cancer;

> TransCelerate BioPharma, a Justice League-like cadre of the world's largest drug developers, is working on a mutual recognition system to evaluate good clinical practices adherence for trial sites. Article

> CRO Accelovance is expanding its staff and clinical capabilities to focus on cancer R&D. News

> Canadian research outfit MannaResearch bought Kells Medical Research Group, a clinical investigator site. Story

> India is struggling to regulate its clinical research industry, balancing patient safety with its interest in maintaining what has become a huge economic contributor for the country. Live Mint weighs in on how the government should move forward. Opinion

> CRO SRI International has discovered a potential biomarker for Huntington's disease, looking at electrical activity in the brains of mouse models that could indicate the disease before major symptoms set in. Item